The triple type 2 signature confers more frequent exacerbations and worse midexpiratory flow in moderate to severe asthma

J Allergy Clin Immunol Pract. 2023 Sep;11(9):2926-2928.e1. doi: 10.1016/j.jaip.2023.05.021. Epub 2023 May 26.

Authors

Rory Chan¹, Brian Lipworth²

Affiliations

¹ Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, Scotland, United Kingdom. Electronic address: rchan@dundee.ac.uk.
² Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, Scotland, United Kingdom.

PMID: 37245731
DOI: 10.1016/j.jaip.2023.05.021

No abstract available

MeSH terms

Asthma*
Humans